259 related articles for article (PubMed ID: 34836947)
1. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic.
Geng MJ; Zhang HY; Yu LJ; Lv CL; Wang T; Che TL; Xu Q; Jiang BG; Chen JJ; Hay SI; Li ZJ; Gao GF; Wang LP; Yang Y; Fang LQ; Liu W
Nat Commun; 2021 Nov; 12(1):6923. PubMed ID: 34836947
[TBL] [Abstract][Full Text] [Related]
2. Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.
Chen L; Wang L; Xing Y; Xie J; Su B; Geng M; Ren X; Zhang Y; Liu J; Ma T; Chen M; Miller JE; Dong Y; Song Y; Ma J; Sawyer S
JMIR Public Health Surveill; 2024 May; 10():e47626. PubMed ID: 38748469
[TBL] [Abstract][Full Text] [Related]
3. Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.
Chang T; Cho SI; Yoo DS; Min KD
Emerg Infect Dis; 2024 Jun; 30(6):1154-1163. PubMed ID: 38781924
[TBL] [Abstract][Full Text] [Related]
4. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.
Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G
Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091
[TBL] [Abstract][Full Text] [Related]
5. The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.
Liu W; Wang R; Li Y; Zhao S; Chen Y; Zhao Y
BMC Public Health; 2023 Jun; 23(1):1089. PubMed ID: 37280569
[TBL] [Abstract][Full Text] [Related]
6. Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.
Chen B; Wang M; Huang X; Xie M; Pan L; Liu H; Liu Z; Zhou P
Front Public Health; 2021; 9():728768. PubMed ID: 34722440
[No Abstract] [Full Text] [Related]
7. Effects of different levels of non-pharmaceutical interventions on hand, foot and mouth disease in Guangzhou, China.
Wu K; Ma X; Liu H; Zheng J; Zhou R; Yuan Z; Huang Z; Zhong Q; Huang Y; Zhang Z; Wu X
BMC Public Health; 2022 Dec; 22(1):2398. PubMed ID: 36539790
[TBL] [Abstract][Full Text] [Related]
8. The COVID-19 epidemic and other notifiable infectious diseases in China.
Bai BK; Jiang QY; Hou J
Microbes Infect; 2022 Feb; 24(1):104881. PubMed ID: 34419605
[TBL] [Abstract][Full Text] [Related]
9. Nonpharmaceutical Interventions Used to Control COVID-19 Reduced Seasonal Influenza Transmission in China.
Lei H; Xu M; Wang X; Xie Y; Du X; Chen T; Yang L; Wang D; Shu Y
J Infect Dis; 2020 Nov; 222(11):1780-1783. PubMed ID: 32898256
[TBL] [Abstract][Full Text] [Related]
10. Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland.
Steffen R; Lautenschlager S; Fehr J
J Travel Med; 2020 Dec; 27(8):. PubMed ID: 33152761
[TBL] [Abstract][Full Text] [Related]
11. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study.
Zhang W; Wu Y; Wen B; Zhang Y; Wang Y; Yin W; Sun S; Wei X; Sun H; Zhang Z; Li S; Guo Y
Infect Dis Poverty; 2023 Mar; 12(1):15. PubMed ID: 36895021
[TBL] [Abstract][Full Text] [Related]
12. The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-A spatiotemporal perspective in Xi'an, northwestern China.
Shen L; Sun M; Song S; Hu Q; Wang N; Ou G; Guo Z; Du J; Shao Z; Bai Y; Liu K
J Med Virol; 2022 Jul; 94(7):3121-3132. PubMed ID: 35277880
[TBL] [Abstract][Full Text] [Related]
13. Interrupted time series analysis using the ARIMA model of the impact of COVID-19 on the incidence rate of notifiable communicable diseases in China.
Zhou Q; Hu J; Hu W; Li H; Lin GZ
BMC Infect Dis; 2023 Jun; 23(1):375. PubMed ID: 37316780
[TBL] [Abstract][Full Text] [Related]
14. Impact of national COVID-19 restrictions on incidence of notifiable communicable diseases in England: an interrupted time series analysis.
Nash K; Lai J; Sandhu K; Chandan JS; Shantikumar S; Ogunlayi F; Coleman PC
BMC Public Health; 2022 Dec; 22(1):2318. PubMed ID: 36510205
[TBL] [Abstract][Full Text] [Related]
15. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017.
Dong Y; Wang L; Burgner DP; Miller JE; Song Y; Ren X; Li Z; Xing Y; Ma J; Sawyer SM; Patton GC
BMJ; 2020 Apr; 369():m1043. PubMed ID: 32241761
[TBL] [Abstract][Full Text] [Related]
16. Public Perceptions and Attitudes Toward COVID-19 Nonpharmaceutical Interventions Across Six Countries: A Topic Modeling Analysis of Twitter Data.
Doogan C; Buntine W; Linger H; Brunt S
J Med Internet Res; 2020 Sep; 22(9):e21419. PubMed ID: 32784190
[TBL] [Abstract][Full Text] [Related]
17. The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis.
Lai CC; Chen SY; Yen MY; Lee PI; Ko WC; Hsueh PR
Travel Med Infect Dis; 2021; 40():101997. PubMed ID: 33640476
[TBL] [Abstract][Full Text] [Related]
18. Quantifying the Impact of COVID-19 Nonpharmaceutical Interventions on Influenza Transmission in the United States.
Qi Y; Shaman J; Pei S
J Infect Dis; 2021 Nov; 224(9):1500-1508. PubMed ID: 34551108
[TBL] [Abstract][Full Text] [Related]
19. Immediate and long-term changes in infectious diseases in China at the "First-level-response", "Normalized-control" and "Dynamic-COVID-zero" stages from 2020 to 2022: a multistage interrupted-time-series-analysis.
Shi T; Zhang X; Meng L; Li D; Jin N; Zhao X; Zheng H; Wang T; Li R; Ren X
BMC Public Health; 2023 Jul; 23(1):1381. PubMed ID: 37464368
[TBL] [Abstract][Full Text] [Related]
20. Changes in Temporal Properties of Notifiable Infectious Disease Epidemics in China During the COVID-19 Pandemic: Population-Based Surveillance Study.
Zhao X; Li M; Haihambo N; Jin J; Zeng Y; Qiu J; Guo M; Zhu Y; Li Z; Liu J; Teng J; Li S; Zhao YN; Cao Y; Wang X; Li Y; Gao M; Feng X; Han C
JMIR Public Health Surveill; 2022 Jun; 8(6):e35343. PubMed ID: 35649394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
